Beverage measurement with a gemstone

2018-10-11 | Corporate A new process sensor has been on the market since the beginning of September: the Cobrix 2600 is theentry-level model for the simultaneous measurement of dissolved carbon dioxide (CO2) and sugarcontent in non-alcoholic beverages. The sensor is integrated directly into the production process via a standardized connection and is of interest to producers... Read more

Fabric Genomics Announces Early Access to ‘Build 38’ for Improved Clinical Genome Analysis

Latest genome reference build offers enhanced interpretation results; improves clinical workflows and patient care, access to diverse population data October 11, 2018 01:26 PM Pacific Daylight Time OAKLAND, Calif.–(BUSINESS WIRE)–Fabric Genomics™, a global leader in clinical interpretation of genomic data, announced today that it is offering select customers the option of using ‘Build 38,’ the... Read more

Setting A New Standard for Breast Care: GE Healthcare Introduces Invenia ABUS 2.0

Chicago – October 11, 2018 – Continuing its efforts to empower clinicians and patients in their fight against breast cancer, GE Healthcare today launched the Invenia Automated Breast Ultrasound (ABUS) 2.0 in the United States. This device is the only FDA-approved ultrasound supplemental breast screening technology, specifically designed for detecting cancer in dense breast tissue. When... Read more

Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing

MinIT is out – an analysis and device control accessory to enable powerful, real-time DNA/RNA sequencing by anyone, anywhere Wed 10th October 2018 MinIT, a rapid analysis and device control accessory for nanopore DNA sequencing, is now arriving with genomics researchers. Scientists will use it to run the MinION DNA/RNA sequencer, opening up high-throughput, real-time... Read more

Pacific Biosciences Announces a New Paradigm in DNA Sequencing – Highly Accurate Single-Molecule Long Reads

Significant Enhancements to Sequel System Enable >99% Accuracy for Single-Molecule Reads up to 15 kb; Throughput Increases by 2- to 4-FoldMENLO PARK, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced major enhancements to its Sequel® System, including... Read more

Pacific Biosciences Announces a New Paradigm in DNA Sequencing – Highly Accurate Single-Molecule Long Reads

Significant Enhancements to Sequel System Enable >99% Accuracy for Single-Molecule Reads up to 15 kb; Throughput Increases by 2- to 4-FoldMENLO PARK, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced major enhancements to its Sequel® System, including... Read more

Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists

In Vitro Diagnostic Device Designed for Dried Blood Spot Analysis MILFORD, Mass.–(BUSINESS WIRE)–Oct. 10, 2018– Waters Corporation (NYSE:WAT) introduced the RenataDX™ Screening System, a flow-injection tandem mass spectrometry (FIA-MS/MS) system for rapid high-throughput analysis of extracted dried blood spots and other human biological matrices. Waters New RenataDX Screening System Delivers Fast, Accurate Results for Clinical Scientists (Photo: Business... Read more

Shimadzu’s New GCMS NX Series Combines Exceptional Accuracy and Sensitivity with Easy Maintenance and Operation

Oct 09 2018 Shimadzu Scientific Instruments (SSI) announces the release of its GCMS NX series gas chromatograph mass spectrometers. The new NX series, which consists of the triple-quad GCMS-TQ8050 NX, the triple-quad GCMS-TQ8040 NX, and the single-quad GCMS-QP2020 NX, combines high accuracy and high sensitivity with easy maintenance and improved operating efficiency. The GCMS NX series systems use... Read more

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

October 9, 2018 Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene editing and personalized medicine technologies, today announced the introduction of a new catalog of over 2000 knockout cell lines and cell lysates. The cell line catalog has been generated using CRISPR-Cas9 technology... Read more